On May 29th, Altor Fund IV (“Altor”) launched a group of dental clinics under the name KonfiDents. KonfiDents is a dental group where key opinion leaders in implantology, dental aesthetics and maxillofacial surgery are joining forces to provide and secure high-quality dental care and reshape the future of the German dental market.
Altor has signed an agreement to acquire the hospital Krankenhaus Maria-Hilf Warstein (“KMH”), which will form the foundation of KonfiDents. Altor has also acquired two dental clinics to date, the Kleinsman Varzideh Dental Center MVZ GmbH, focused on dental aesthetics, and the Palti Dentalzentrum MVZ GmbH, focused on implantology. Through this platform, Altor will continue to grow KonfiDents by acquiring best-practice dental clinics. KonfiDents offers patients consistent superior quality procedures and aims to secure access to high-quality dental care across Germany.
Altor is partnering with Prof. Dr. Margarete Bowien and Martin Hagedorn, founders of KonfiDents, and KMH’s current majority owners Deutsche Klinik Union who will continue to manage the hospital.
”We are very excited to be able to launch KonfiDents and start shaping the future of specialist dental care in Germany together with our dentist partners“, says Andreas Källström Säfweräng, Partner at Altor.
KonfiDents has also entered into a cooperation with Haranni Academy, one of the leading dental academies in Germany, to found KonfiDents Academy.
“The KonfiDents Academy is at the core of the quality promise that KonfiDents stands for,” says Prof. Dr. Margarete Bowien, co-founder of KonfiDents.
“I am thrilled to be a part of this new group of dental clinics with a focus on high-quality practices and niche competence in a field where I have spent my entire career. I believe that this is the future of dental care in Germany,” says Professor Jan-Michaél Hirsch, board member of KonfiDents and Professor Emeritus in Oral and Maxillofacial Surgery at Uppsala University.
The transaction is subject to customary regulatory requirements and approvals.